Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Review

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

         
Total article views   Abstract views HTML views PDF downloads Totals
16,709 Dovepress* 12,351 655+ 2,351 13,006
PubMed Central* 20 3,683 766 3,703
Totals 12,371 4,338 3,117 16,709
*Since 10 November 2010
+Since July 2016

View citations on PubMed Central and Google Scholar